On top of that, FDA is proposing two other restrictions on the submission of the supplemental PMTA. Less than proposed § 1114.fifteen(a), a supplemental PMTA couldn't be submitted exactly where the marketing buy for the initial tobacco product has been withdrawn or has long been b